Effect of hyperbaric oxygen and ulinastatin on plasma endotoxin, soluble CD14, endotoxin-neutralizing capacity and cytokines in acute necrotizing pancreatitis

Canadian Journal of Surgery

Volumn 53, Issue 4, 2010, Pages 241-245

  Hou, Jing ^a   Zhu, Ming Wei ^b   He, Xiu Wen ^b   Wei, Jun Ming ^b   Li, Yong Guo ^c   Tang, Da Nian ^b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b BEIJING HOSPITAL   (China)

^c CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; CYTOKINE; ENDOTOXIN; GLYCOPROTEIN; INTERLEUKIN 6; TRYPSIN INHIBITOR; TUMOR NECROSIS FACTOR ALPHA; ULINASTATIN;

ANIMAL; BLOOD; COMPARATIVE STUDY; DISEASE MODEL; DRUG EFFECTS; ENZYME LINKED IMMUNOSORBENT ASSAY; HYPERBARIC OXYGEN; INTRAVENOUS DRUG ADMINISTRATION; MALE; PANCREATITIS, ACUTE NECROTIZING; PROCEDURES; RAT; SPRAGUE DAWLEY RAT; TREATMENT OUTCOME;

ANIMALS; ANTIGENS, CD14; CYTOKINES; DISEASE MODELS, ANIMAL; ENDOTOXINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLYCOPROTEINS; HYPERBARIC OXYGENATION; INFUSIONS, INTRAVENOUS; INTERLEUKIN-6; MALE; PANCREATITIS, ACUTE NECROTIZING; RATS; RATS, SPRAGUE-DAWLEY; TREATMENT OUTCOME; TRYPSIN INHIBITORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77955359161     PISSN: 0008428X     EISSN: 14882310     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Beger HG, Bittner R, Block S, et al. Bacterial contamination of pancreatic necrosis: a prospective clinical study. Gastroenterology 1986;91:433-8.
2. Glauser MP, Zanetti AG, Baumgartner JD, et al. Septic shock: pathogenesis. Lancet 1991;338:732-6.
3. Hiki N, Berger D, Buttenshcoen K, et al. Endotoxemia and specific antibody behavior against different endotoxins following multiple injuries. J Trauma 1995;38:794-801.
4. Landmann R, Reber AM, Sansano S, et al. Function of soluble CD14 in serum from patients with septic shock. J Infect Dis 1996;173:661-8.
5. Yaegashi Y, Shirakawa K, Sato N, et al. Evaluation of a newly identified soluble CD14 subtye as a marker for sepsis. J Infect Chemother 2005;11:234-8.
6. Berger D, Schleich S, Seidelmann M, et al. Correlation between endotoxin-neutralizing capacity of human plasma as tested by the limulus-amebocyte-lysate-test and plasma protein levels. FEBS Lett 1990;277:33-6.
7. Bose SM, Verma GR, Mazumadar A, et al. Significance of serum endotoxin and antiendotoxin antibody levels in predicting the severity of acute pancreatitis. Surg Today 2002;32:602-7.
8. Chen HM, Shyr MH, Ueng SW, et al. Hyperbaric oxygen therapy attenuates pancreatic microcirculatory derangement and lung edema in an acute experimental pancreatitis model in rats. Pancreas 1998;17:44-9.
9. Izawa K, Tsundoa T, Ura K, et al. Hyperbaric oxygen therapy in treatment of refractory pancreatic abscesses associated with serious acute pancreatitis. Gastroenterol Jpn 1993;28:284-91.
10. Aibiki M, Cook JA. Ulinastatin, a human trypsin inhibitor, inhibits endotoxin-induced thromboxane B2 production in human mono-cytes. Crit Care Med 1997;25:430-4.
11. Aosasa S, Ono S, Mochizuki H, et al. Mechanism of the inhibitory effect of protease inhibitor on tumor necrosis factor alpha production of monocyte. Shock 2001;15:101-5.
12. Kaplan O, Kaplan D, Casif E, et al. Effects of delayed administration of octreotide in acute experimental pancreatitis. J Surg Res 1996;62:109-17.
13. Cohen J, Maconnell JS. Observation on the measurement and evaluation of endotoxemia by a quantitative limulus lysate microassay. J Infect Dis 1984;150:916-24.
14. Buttenschoen K, Buttenschoen DC, Berger D, et al. Endotoxin and acute-phase protein in major abdominal surgery. Am J Surg 2001;181:36-43.
15. Lin CY, Tsai IF, Ho YP, et al. endotoxemia contributes to the immune paralysis in patients with cirrhosis. J Hepatol 2007;46:816-26.
16. Opal SM, Gluck T. Endotoxin as a drug target. Crit Care Med 2003;31(Suppl): S57-64.
17. Sessler CN, Bloomfiled GL, Flower AA. Current concept of sepsis and acute lung injury. Clin Chest Med 1996;17:213-6.
18. Golenbock DT, Bach RR, Lichenstein TS, et al. Soluble CD14 promote LPS activation of CD14-deficicent PNH and endothelial cell. J Lab Clin Med 1995;125:662-7.
19. Moore KJ, Andersson LP, Ingalls RR, et al. Divergent response to LPS and bacterial in CD14-deficient murine macrophages. J Immunol 2000;165:4272-80.
20. Chow JC, Young DW, Golenbock DT, et al. Toll-like receptor 4 mediates lipopolysaccharide-induced signal transduction. J Biol Chem 1999;274:10689-92.
21. Wang X, Wu LY, Wu K, et al. Role of endotoxin-related signaling molecules in the progression of acute necrotizing pancreatitis in mice. Pancreas 2005;31:251-7.
22. Rahman SH, Salter G, Holmfield JHM, et al. Soluble CD14 receptor expression and monocyte heterogeneity but not the C-260T CD14 genotype are associated with severe acute pancreatitis. Crit Care Med 2004;32:2457-63.
23. Schimke J, Mathison J, Morgiewicz J, et al. AntiCD14 mAb treatment provides therapeutic benefit after in vivo exposure to endo-toxin. Proc Natl Acad Sci U S A 1998;95:13875-80.
24. Bennett-Guerrero E, Ayuso L, Hamilton-Davies C, et al. Relationship of preoperative antiendotoxin core antibody and adverse outcome following cardiac surgery. JAMA 1997;277:646-50.
25. Di Padova FE, Brade H, Barclay GR, et al. A broadly cross-protective monoclonal antibody binding to Escherichia coli and Salmonella lipopolysaccharides. Infect Immun 1993;61:3863-72.
26. Chen HM, Shyr MH, Ueng SW, et al. Hyperbaric oxygen therapy attenuates pancreatic microcirculatory derangement and lung edema in an acute experiment pancreatitis model in rats. Pancreas 1998;17:44-9.
27. Cuthberston CM, Nikfarjam M, Su K, et al. Hyperbaric oxygen reduces severity and improves survival in acute pancreatitis [abstract]. Pancreas 2005;31:437.
28. Mas N, Isik AT, Mas MR, et al. Hyperbaric oxygen-induced changes in bacterial translocation and acinar ultrastructure in rat acute necro-tizing pancreatitis. J Gastroenterol 2005;40:980-6.
29. Yasar M, Yildiz S, Mas R, et al. The effect of hyperbaric oxygen treatment on oxidative stress in experimental acute necrotizing pzn-creatitis. Physiol Res 2003;52:111-6.
30. Cuthbertson CM, Christophi CC. Potential effect of hyperbaric oxygen therapy in acyte pancreatitis. ANZ J Surg 2006;76:625-30.
31. Ueki T, Otani K, Kawamoto K, et al. Comparison between ulinas-tatin and gabexate mesylate for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a prospective, randomized trial. J Gastroenterol 2007;42:161-7.
32. Fitzal F, Delano FA, Young C, et al. Pancreatic enzymes sustain system inflammation after an initial endotoxin challenge. Surgery 2003;134:446-56.
33. Inoue K, Takano H, Shimada A, et al. Urinary trypsin inhibitor protects against systemic inflammation induced by lipopolysaccharide. Int J Mol Med 2005;16:1029-33.
34. Fujishiro H, Adachi K, Imaoka T, et al. Ulinastatin shows preventive effect on post-endoscopic retrograde cholangiopancreatography pancreatitis in a multicenter prospective randomized study. J Gastroen-terol Hepatol 2006;21:1065-9.